Rebhan Dissertation ohne Lebenslauf - OPUS - Universität Würzburg

43. Brown NJ, Nadeau JH, Vaughan DE. Selective stimulation of tissue-type
plasminogen activator (t-PA) in vivo by infusion of bradykinin. Thromb
Haemost 77: 522-5, 1997.
44. Minai K, Matsumoto T, Horie H, Ohira N, Takashima H, Yokohama H,
Kinoshita M. Bradykinin stimulates the release of tissue plasminogen
activator in human coronary circulation: effects of angiotensin-converting
enzyme inhibitors. J Am Coll Cardiol 37: 1565-70, 2001.
45. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y,
Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide
produced by vascular endothelial cells. Nature 332: 411-5, 1988.
46. Pagano PJ, Lin L, Sessa WC, Nasjletti A. Arachidonic acid elicits
endothelium-dependent release from the rabbit aorta of a constrictor
prostanoid resembling prostaglandin endoperoxides. Circ Res 69: 396-
405, 1991.
47. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases
endothelial superoxide anion production. J Clin Invest 91: 2546-51, 1993.
48. Vanhoutte PM, Feletou M, Taddei S. Endothelium-dependent
contractions in hypertension. Br J Pharmacol 144: 449-58, 2005.
49. Dzau VJ. Local expression and pathophysiological role of renin-
angiotensin in the blood vessels and heart. Basic Res Cardiol 88 Suppl
1: 1-14, 1993.
50. Black MJ, Dilley RJ, Bobik A. Renin-dependent hypertension induces
smooth muscle polyploidy in large and small vessels. J Hypertens Suppl
11: S118-S119, 1993.
51. Agrest A. [The renin saga]. Medicina (B Aires) 60: 37-45, 2000.